posted on Feb, 24 2005 @ 02:42 PM
New Scientist has a long article about the renewed interest among scientists in the possible medical uses of psychedelic drugs like '___', Psilocybin,
'___', and Ketamine: Since 2001, psychiatrist Francisco Moreno of the University of Arizona in Tucson has been testing psilocybin as a treatment for
obsessive-compulsive disorder. Psychotherapy and antidepressants such as Prozac help many patients, but some have such severe symptoms and are so
resistant to treatment that they turn to electroshock therapy and even brain surgery. As with the work on cluster headaches, Moreno's study was
motivated by reports from people with OCD that psilocybin relieves their symptoms.
So far, Moreno has given both sub-psychedelic and psychedelic doses of pure psilocybin to nine treatment-resistant OCD subjects, in a total of 29
therapy sessions. His preliminary findings suggest firstly that it is safe to ingest psilocybin, which was a primary concern of the trial. Beyond
that, Moreno calls his results "promising", but won't discuss them further, since he plans to submit a paper to a peer-reviewed journal this year.
more info at: www.boingboing.net...
editted to add link
[edit on 24-2-2005 by Zabilgy]